Eckert & Ziegler BEBIG supports Brachytherapy Program within the Horizon Health Network in North America
(Thomson Reuters ONE) -
Seneffe, Belgium, September 18, 2013, Eckert & Ziegler BEBIG announces its
support of the brachytherapy program at Saint John Regional Hospital, Saint
John, in the province of New Brunswick, Canada, which is part of the Horizon
Health Network.
The Adult Oncology Centre at Saint John Regional Hospital, employing five
Radiation Oncologists and two Medical Oncologists, has been designated as a
tertiary centre for Radiation Oncology and is at the forefront of
multidisciplinary cancer care in the province.
"Brachytherapy is an established technique commonly used as a boost in
combination with other cancer therapies as well as a monotherapy. In the past,
we had to send our patients to other hospitals to receive brachytherapy
treatments. With our new high dose rate (HDR) brachytherapy program supported by
Eckert & Ziegler BEBIG, we will be able to offer convenient access to an
additional clinical option for our cancer patients." states Dr. Holly Campbell,
Radiation Oncologist.
The medical devices made available for the program by Eckert & Ziegler BEBIG
included the state-of-the-art MultiSource® HDR afterloader. The system is in use
in medical facilities in almost 40 countries worldwide and offers exclusive
features like the fully integrated In-Vivo Dosimetry for real time dose
monitoring. This feature along with the automatic catheter length measurement
and the precise source position check underline the afterloader's reputation of
enabling for a high level of accuracy. Furthermore, the MultiSource® HDR
afterloader runs with either an Iridium-192 or a particularly cost-effective
Cobalt-60 source.
Additionally, the Saint John Regional Hospital is using the treatment planning
software HDRplus(TM) 3.0. The software supports all HDR applications, including
intracavitary, interstitial, intraluminal as well as intraoperative treatments
by offering a complete applicator database, automatic applicator reconstruction,
automatic image fusion and the integrated Prostate Module.
"We are proud to have the opportunity together with our Canadian distributor CSP
Medical, a leading North American medical device distributor, to support Saint
John Regional Hospital with our first afterloader installation in Canada along
with the corresponding HDR treatment planning software and a variety of
applicators." states Abel Luzuriaga, Managing Director of Eckert & Ziegler
BEBIG. "With more than 10 years in use in various medical facilities, our
MultiSource® system has proven a high level of effectivity and reliability.
Thereby, custom-tailored support and quality 'Made in Germany' are just two of
our company principles."
The first HDR brachytherapy patient at the Saint John Regional Hospital already
completed treatment. Dr. Jon Dysart, Medical Physicist in the 444-bed hospital,
explains: "Since in the beginning of the program, we are focusing on
gynaecological HDR brachytherapy, our first treatment carried out was a
gynaecological therapy with a vaginal cylinder. In the near future, we will also
offer HDR brachytherapy for a full range of clinical cases. We have been given
strong support and guidance throughout the installation, commissioning and
applications training by Eckert & Ziegler BEBIG and CSP Medical prior to
initiating the clinical program. With this support we were able to initiate our
planned brachytherapy program quickly and are looking forward to extend it
soon."
For more information regarding the MultiSource® system, please see
http://www.bebig.eu/home/products/hdr-brachytherapy.html
About the Horizon Health Network
Horizon Health Network is the largest health-care organization in Atlantic
Canada serving New Brunswick, northern Nova Scotia and Prince Edward Island. It
operates more than 100 facilities including hospitals, community health centres
& clinics, Addiction Services, Mental Health services, Public Health and Extra
Mural Program.
With approximately 1,000 physicians, an annual operating budget exceeding C$ 1
billion and over 13,000 staff, Horizon Health Network plays a major role in
research, innovation, education and health and wellness.
About Eckert & Ziegler BEBIG
Contributing to saving lives!
Eckert & Ziegler BEBIG is a European-based group active in the medical device
segment of the health care industry. Its core business is the treatment of
cancer using brachytherapy, a special form of radiation therapy. Eckert &
Ziegler BEBIG is a leader in brachytherapy in Europe. The company headquarters
are in Belgium, with R&D and production facilities in Germany and subsidiaries
throughout Europe, in India and Brazil. In addition, Eckert & Ziegler BEBIG has
a worldwide network of distributors and agents to support the international
marketing of its product line. The company's products and equipment are intended
for use by oncologists, radiologists, urologists, and medical physicists. Eckert
& Ziegler BEBIG employs more than 150 people. The company has been listed on the
Euronext stock exchange since April 1997.
Contact:
Claudia Wolf
Head of Marketing
Tel: +49 30 94 10 84 272
marketing(at)bebig.eu
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Eckert & Ziegler BEBIG via Thomson Reuters ONE
[HUG#1729835]
Unternehmensinformation / Kurzprofil:
Datum: 18.09.2013 - 09:59 Uhr
Sprache: Deutsch
News-ID 297720
Anzahl Zeichen: 6207
contact information:
Town:
Seneffe
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 223 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Eckert & Ziegler BEBIG supports Brachytherapy Program within the Horizon Health Network in North America"
steht unter der journalistisch-redaktionellen Verantwortung von
Eckert & Ziegler BEBIG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
